SCHEMBL15840473

SCHEMBL15840473

CC(C)CCC(=O)N1CCC(c2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS5 Q9UNA0 3/20 0.58
▸ HRH3 Q9Y5N1 2/20 0.57
▸ KCNH2 Q12809 1/20 0.57
▸ ALDH1A1 P00352 3/20 0.55
▸ POLB P06746 1/20 0.55
▸ MAPK1 P28482 2/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ LIPE Q05469 1/20 0.50
▸ PARP1 P09874 1/20 0.50
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ NAMPT P43490 1/20 0.49
▸ PRCP P42785 1/20 0.49
▸ RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005883 0.86 ALDH1A1 (0.56) ALDH1A1POLBMAPK1SMN1; SMN2LMNA
SCHEMBL25653340 0.86 ALDH1A1 (0.56) ALDH1A1POLBMAPK1SMN1; SMN2LMNA
SCHEMBL19703077 0.84 ADAMTS5 (0.57) ADAMTS5HRH3KCNH2ALDH1A1POLB
SCHEMBL4198757 0.84 NAMPT (0.65) ADAMTS5HRH3KCNH2ALDH1A1POLB
SCHEMBL25443738 0.82 ADAMTS5 (0.43) ADAMTS5HRH3KCNH2MAPK1
SCHEMBL6245254 0.82 NAMPT (0.64) ADAMTS5HRH3KCNH2ALDH1A1POLB
SCHEMBL27014443 0.81 ALDH1A1 (0.61) HRH3KCNH2ALDH1A1POLBRAB9A
SCHEMBL4034093 0.80 ALDH1A1 (0.57) ADAMTS5HRH3KCNH2ALDH1A1POLB
SCHEMBL28154396 0.79 ACACB (0.47) ADAMTS5KCNH2NAMPT
SCHEMBL14672010 0.79 HRH3 (0.56) ADAMTS5HRH3KCNH2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957249-B2 Saturated nitrogen and N-acylated heterocycles potentiating the activity of an active antibiotic against Mycobacteria UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2018-05-01 — — US disclosed
US-9957249-B2 Saturated nitrogen and N-acylated heterocycles potentiating the activity of an active antibiotic against Mycobacteria UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2018-05-01 — — US disclosed
US-20150307471-A1 Saturated Nitrogen and N-Acylated Heterocycles Potentiating the Activity of an Active Antibiotic against Mycobacteria UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2015-10-29 — — US disclosed
US-20150307471-A1 Saturated Nitrogen and N-Acylated Heterocycles Potentiating the Activity of an Active Antibiotic against Mycobacteria UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2015-10-29 — — US disclosed
WO-2014096378-A1 SATURATED NITROGEN AND N-ACYLATED HETEROCYCLES POTENTIATING THE ACTIVITY OF AN ACTIVE ANTIBIOTIC AGAINST MYCOBACTERIA UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307471-A1 Saturated Nitrogen and N-Acylated Heterocycles Potentiating the Activity of an Active Antibiotic against Mycobacteria NAT1, NAA15, FNTB ADAMTS5 4736/4885HRH3 1205/4885KCNH2 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback